(Q37245244)

19 August 2017

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study (English)

1 reference

19 August 2017

1 reference

1 reference

9

Charles Kooperberg

1 reference

19 August 2017

5

0 references

Lewis Kuller

10

object named as

Lewis H Kuller

1 reference

19 August 2017

4

Joann E Manson

1 reference

19 August 2017

3

Marcia L Stefanick

1 reference

19 August 2017

2

Rowan T Chlebowski

1 reference

19 August 2017

15

Garnet L Anderson

1 reference

19 August 2017

7

Susan L Hendrix

1 reference

19 August 2017

12

Anne McTiernan

1 reference

19 August 2017

11

Dorothy S Lane

1 reference

19 August 2017

8

F Allan Hubbell

1 reference

19 August 2017

Ross L Prentice

1

1 reference

19 August 2017

Mary Pettinger

6

1 reference

19 August 2017

Mary Jo O'Sullivan

13

1 reference

19 August 2017

Jacques E Rossouw

14

1 reference

19 August 2017

language of work or name

English

0 references

publication date

29 April 2008

1 reference

American Journal of Epidemiology

19 August 2017

1 reference

19 August 2017

167

1 reference

19 August 2017

12

1 reference

19 August 2017

1407-1415

1 reference

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

The Women's Health Initiative recruitment methods and results

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Breast cancer and hormone-replacement therapy in the Million Women Study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Problems due to small samples and sparse data in conditional logistic regression analysis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703736

Outcomes ascertainment and adjudication methods in the women's health initiative

14 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18448442

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18448442

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18448442

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/AJE/KWN090

1 reference

19 August 2017

1 reference

19 August 2017

1 reference